Most randomized controlled trials forpsoriasis used placebo comparators despite the availability of effective treatments
Most randomized controlled trials forpsoriasis used placebo comparators despite the …
Meta-analysis results do not reflect the real safety of biologics in psoriasis
Meta-analysis results do not reflect the real safety of biologics …
Meta-analysis results do not reflect the real safety of biologics in psoriasis Read More »
Quality and Reporting Completeness of Systematic Reviews and Meta-Analyses in Dermatology
Quality and Reporting Completeness of Systematic Reviews and Meta-Analyses in …
Influence of sex on the persistence of different classes of targeted therapies for psoriatic arthritis: a cohort study of 14 778 patients from the French health insurance database (SNDS)
Influence of sex on the persistence of different classes of …
Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database
Adverse events associated with JAK inhibitors in 126,815 reports from …
Psoriasis-related treatment exposure and hospitalization or in-hospital mortality due to COVID-19 during the first and second wave of the pandemic: cohort study of 1 326 312 patients in France
Psoriasis-related treatment exposure and hospitalization or in-hospital mortality due to …
Paradoxical reactions and biologic agents: a French cohort study of 9 303 patients
Paradoxical reactions and biologic agents: a French cohort study of …
Paradoxical reactions and biologic agents: a French cohort study of 9 303 patients Read More »
Association Between Biologics Use and Risk of Serious Infection in Patients With Psoriasis
Association Between Biologics Use and Risk of Serious Infection in …
Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study
Risk of major adverse cardiovascular events in patients initiating biologics/apremilast …
Risk of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis initiating interleukin 17 inhibitors: a nationwide population-based study using the French national health data system
Background Sex differences in phenotype presentation, disease trajectory and treatment …